Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think company is going to drop the big hammer in the morning.
This is a very smart company.
Only the most vital and material updates are provided.
They also know that the markets are closed on Monday.
So timing would be perfect to take this past 50 cents.
This is jus a massive buying opportunity lot of people had been waiting for.
It is going back up.
Markets are closed on Monday.
I think OWCP is going to drop the big hammer either after the close today or tomorrow morning.
We all know it is coming.
Dip is done.
Now the climb is on track again.
Shorts and flippers will get run over.
Way too much momentum here.
And massive pent up demand.
People want in.
manipulation has created a fantastic opportunity for the folks to finally load this at slightly better prices.
this will close green today and it will close well north of 41 cents.
it was manipulation that did not last.
stock gave us all a glimpse of where it is going very early this morning.
this closes well north of 41 cents today.
too much momentum and too much pent up demand for this stock.
I have a feeling that it may even make a run to 50 cents today.
40 cents is ancient history after this morning.
Shorts will get run over.
This stock is eying 50 cents.
Sensational momentum here.
this is going a lot higher.
this is just the beginning.
this will be one of the most epic runs ever seen in a medical cannabis stock.
fabulous momentum here.
this could make a run to 50 cents today.
there is some manipulation going on this very second.
shorts and flippers will get run over.
there is massive pent up demand for this stock.
stock wants to run and it cant be stopped right now.
load the dips. 40 cents is done forever after this morning.
I see no pullbacks today.
only a very minor dip.
and I do mean a very minor dip.
any and all minor dips are going to get chewed up.
time to snatch this under 40 cents will vanish very rapidly this morning.
volume of over 10 million yesterday means that the momentum will carry into today.
accumulate the hell out of this stock. 40 cents is done forever very shortly.
the word is getting out all over social media.
smart money has been slowly accumulating this.
OWCP:
**********accumulate the hell out of this stock
1. too many catalysts in play at OWCP
2. awesome volume yesterday
3. smart money accumulating this
4. tremendous momentum
translation: this momentum carries into today. I think it is going to run hard.
https://www.insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-on-a-bull-run/118980/
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is following the game plan we laid out for our subscribers back in November. We said that the stock was going to consolidate before heading higher. Shares have done just that and made new 52 week highs. OWCP is now up almost 8000% in the past year.
What’s most surprising is that even with the current gains, OWCP sports a market cap of just $33 million. When you consider that Medical Marijuana Inc (OTCMKTS:MJNA) has a $520 million market cap, Cannabis Sativa Inc (OTCMKTS:CBDS) a $119 million market cap, or Cannabis Science Inc (OTCMKTS:CBIS) a $157 million market cap, it’s easy to make the case OWCP remains undervalued compared to its peers. Furthermore, there are a number of upcoming catalysts that we believe can keep OWCP on its upward trajectory.
First up, a little background on the company. OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWCP is also developing unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWCP research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
Israel is considered one of the best places in the world for cannabis research. According to The Cannabist, “Unlike the U.S. government, the Israeli government has had few restrictions on doing research on cannabis, whether basic science or clinical studies.” OWCP says that its research division “leverages the Company’s extensive network comprising some of Israel’s leading researchers, scientists, universities and hospitals, as well as cannabis breeders and extractors, to study and test the effectiveness of different combinations of cannabinoids in the treatment of disease and chronic conditions.”
To date, OWCP has signed three research collaboration and license agreements with Sheba Academic Medical Center, Tel Hashomer, Israel. Sheba is a university-affiliated hospital that serves as Israel’s national medical center and the most comprehensive medical center in the Middle East. Within the framework of the agreements with Sheba, OWCP will initiate three studies at the Sheba facilities to explore the effect of three formulations, all based on active ingredients in the cannabis extracts, on multiple myeloma, psoriasis and fibromyalgia (a specific formulation to each indication).
The Company has also signed a Memorandum of Understanding with Emilia Cosmetics Ltd., a large Israeli private label manufacturer, for the development, manufacture and marketing of a cannabinoid-based topical cream to treat psoriasis. The Company will initiate the development of the topical cream at Emilia Cosmetics labs located in Yerucham, Israel. After the completion of the formulation development, the Company will initiate a phase I study at the Sheba facilities to explore the effect of topical cream on psoriasis.
In October, OWCP completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the Tablet is protected and provides for the ingestion of virtually any dosage of medical cannabis with a sublingual delivery mechanism, whereby the compounds are absorbed directly into the patient’s blood through oral epithelial tissue. The Tablet also enables physicians to safely and accurately monitor the dosage and treatment of each individual patient, something that is essentially impossible to do for patients who administer cannabis by smoking.
OWCP is working towards having the Tablet approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use within the country’s sanctioned medical cannabis program, as well as talking with potential licensees of the technology in the United States. Longer term, management expects to establish clinical tests of the Tablet in protocols for Multiple Myeloma, Post-Traumatic Stress Disorder (PTSD), and Fibromyalgia.
now get ready for real firewroks.
OWCP is just warming up.
best is yet to come.
smart money wants this stock.
https://www.insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-on-a-bull-run/118980/
I hear ya mate.
this is a must own stock for everyone who knows and understands that medical cannabis based medicine is the next frontier in medicine.
OWCP is at the forefront of this revolution.
https://www.insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-on-a-bull-run/118980/
this is simply must read article for all newcomers here and even the old timers:
https://www.insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-on-a-bull-run/118980/
anything under 50 cents is a total and complete steal at this point.
we have the best research and development team on the planet.
and we have top flight leadership.
OWCP was named by some investor magazine as one of the 20 best companies on the planet in the medical cannabis space.
this stock is very seriously undervalued.
some of the clowns will find that out soon enough.
I hope they can count to 2 at least.
this stock hits $2 in april or sooner.
I added 3 times.
I am out of cash.
I am making more available to add next week.
my objectives are simple with this stock: I find a way to add each and every single week.
and 100% of my shares are fully locked up.
or you can just watch this skyrocket into outer space.
this will continue tomorrow mate.
massive buying pressure. immense pent up demand for this stock.
it is still very deeply undervalued.
smart money is eying this stock and has started snatching up shares.
this stock is going to run up to $100 in time.
that may take some time but $2 is far closer than some may think or believe.
right now anything under $1 is a bloody steal.
anything under 50 cents is a highway robbery in broad daylight.
lock up 100% of your shares. they are going to be in immense demand.
smart money is all over this stock.
this bull run in this robust stock is in the formative/beginning stages.
do not take this stock lightly.
this stock is going to change lives.
OWCP leadership is on record for saying that they will be bigger than GWPH.
forget the song.
make plans to go to Reno once this hits $5.
we need to get a group together.
we will sip 15 year old scotch and celebrate in Reno.
I am general Clay Death the Destroyer.
Camelot is the global forum that I own.
you can follow me on twitter also. I have over 26,000 followers.
https://twitter.com/claydeath1
momentum is absolutely sensational.
this bull run in this stock is just in the beginning stages.
that means stock is just warming up.
why is it starting to run?
1. deeply undervalued
2. investment community is learning about OWCP
3. too many catalysts in play at OWCP
4. momentum
5. volume
6. massive pent up demand for this stock
7. some smart money is rolling in
translation: this momentum is going to carry into tomorrow.
there will be a very minor dip in the morning. it will be very short lived.
window will be very brief to snatch this under 40 cents.
this is likely to close around 41 cents to 43 cents tomorrow.
but if company drops the big hammer then all best are off.
then it climbs like a mountain goat on jet fuel.
OWCP: this is a must own stock at this point and it is still deeply undervalued.
don't screw this up. this is your opportunity to make some really big bucks. accumulate the hell out of this stock.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) On A Bull Run
By Alex Carlson / in Biotech & Pharma, Momentum Stocks, Sector Watch, Stocks / on Tuesday, 10 Jan 2017 03:48 AM /
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is following the game plan we laid out for our subscribers back in November. We said that the stock was going to consolidate before heading higher. Shares have done just that and made new 52 week highs. OWCP is now up almost 8000% in the past year.
What’s most surprising is that even with the current gains, OWCP sports a market cap of just $33 million. When you consider that Medical Marijuana Inc (OTCMKTS:MJNA) has a $520 million market cap, Cannabis Sativa Inc (OTCMKTS:CBDS) a $119 million market cap, or Cannabis Science Inc (OTCMKTS:CBIS) a $157 million market cap, it’s easy to make the case OWCP remains undervalued compared to its peers. Furthermore, there are a number of upcoming catalysts that we believe can keep OWCP on its upward trajectory.
First up, a little background on the company. OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWCP is also developing unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWCP research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
Israel is considered one of the best places in the world for cannabis research. According to The Cannabist, “Unlike the U.S. government, the Israeli government has had few restrictions on doing research on cannabis, whether basic science or clinical studies.” OWCP says that its research division “leverages the Company’s extensive network comprising some of Israel’s leading researchers, scientists, universities and hospitals, as well as cannabis breeders and extractors, to study and test the effectiveness of different combinations of cannabinoids in the treatment of disease and chronic conditions.”
To date, OWCP has signed three research collaboration and license agreements with Sheba Academic Medical Center, Tel Hashomer, Israel. Sheba is a university-affiliated hospital that serves as Israel’s national medical center and the most comprehensive medical center in the Middle East. Within the framework of the agreements with Sheba, OWCP will initiate three studies at the Sheba facilities to explore the effect of three formulations, all based on active ingredients in the cannabis extracts, on multiple myeloma, psoriasis and fibromyalgia (a specific formulation to each indication).
The Company has also signed a Memorandum of Understanding with Emilia Cosmetics Ltd., a large Israeli private label manufacturer, for the development, manufacture and marketing of a cannabinoid-based topical cream to treat psoriasis. The Company will initiate the development of the topical cream at Emilia Cosmetics labs located in Yerucham, Israel. After the completion of the formulation development, the Company will initiate a phase I study at the Sheba facilities to explore the effect of topical cream on psoriasis.
In October, OWCP completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the Tablet is protected and provides for the ingestion of virtually any dosage of medical cannabis with a sublingual delivery mechanism, whereby the compounds are absorbed directly into the patient’s blood through oral epithelial tissue. The Tablet also enables physicians to safely and accurately monitor the dosage and treatment of each individual patient, something that is essentially impossible to do for patients who administer cannabis by smoking.
OWCP is working towards having the Tablet approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use within the country’s sanctioned medical cannabis program, as well as talking with potential licensees of the technology in the United States. Longer term, management expects to establish clinical tests of the Tablet in protocols for Multiple Myeloma, Post-Traumatic Stress Disorder (PTSD), and Fibromyalgia.
Currently trading with a market cap of $33 million, there are presently 139 million shares outstanding and 86 million shares in the float. We are expecting news from the company any day now regarding its Tablet and/or its psoriasis topical cream. Either one will have the shorts scrambling and keep OWCP making new highs. In light of its low market cap compared to its peers, OWCP looks to be a must-own for cannabis investors. We will be updating our subscribers as soon as we know more. For the latest
Great post.
Can you re-post that again for our newcomers.
Also send it to me in my personal message here so I can post it all over social media.
$1.20 to $1.30 is in view.
Don't let go of your shares.
They will be in very high demand.
Last time I checked gwph had 67 percent institutional ownership.
OWCP is the next gwph.
Only we are going to far bigger in time.
OWCP is deeply undervalued.
If company drops the big hammer in the morning it will gap up and finish the day around 50 cents or better.
Smart money has been snatching this up.
They are running over the small time flippers and shorts.
This is only the beginning.
Best is yet to come.
After tomorrow it will take 50 cents to get in and have decent position.
With this momentum and with the smart money snatching this up I think it will hit 45 cents to 46 cents tomorrow.
Should be a strong close.
Let the cowards run to the hills.
Cowards die 1000 deaths a day and die broke.
You want to own this stock right now.
Time to snatch this under 40 cents is going to vanish forever very quickly.
This is trading around 55 cents to 60 cents in a blink of an eye.
Momentum and pent up demand for this stock is out of this world.
Great post.
Smart money wants this.
This is your greatest buying signal.
This is where you step forward and add more.